Effect of ecteinascidin-743 on the interaction between DNA binding proteins and DNA - PubMed (original) (raw)
Affiliations
- PMID: 10500494
Effect of ecteinascidin-743 on the interaction between DNA binding proteins and DNA
M Bonfanti et al. Anticancer Drug Des. 1999 Jun.
Abstract
Ecteinascidin-743 (ET-743) is a tetrahydroisoquinoline alkaloid isolated from Ecteinascidia turbinata, a tunicate growing in mangrove roots in Caribbean. It has been shown to bind in the minor groove of DNA forming covalent adducts by reaction of the N2 of guanine with the carbinolamine moiety. We investigated ET-743 ability to inhibit the binding of different transcription factors to their consensus sequences by using gel shift assays. We have selected three types of factors: (i) oncogene products such as MYC, c-MYB and Maf; (ii) transcriptional activators regulated during the cell cycle as E2F and SRF; and (iii) general transcription factors such as TATA binding protein (TBP), Sp1 and NF-Y. We observed no inhibition of the binding of Sp1, Maf, MYB and MYC. Inhibition of DNA binding was observed for TBP, E2F, SRF at ET-743 concentrations ranging from 50 to 300 microM. The inhibition of binding of NF-Y occurs at even lower concentrations (i.e. 10-30 microM) when the recombinant subunits of NF-Y are preincubated with the drug, indicating that the inhibition of NF-Y binding does not require previous ET-743 DNA binding. Since NF-Y is a trimer containing two subunits with high resemblance to histones H2B and H2A, we have investigated the effect of ET-743 on nucleosome reconstitution. ET-743 caused a decrease of the nucleosomal band at 100 nM, with the complete disappearance of the band at 3-10 microM. These data suggest that the mode of action of this novel anticancer drug is related to its ability to modify the interaction between some DNA binding proteins and DNA.
Similar articles
- Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743.
Minuzzo M, Marchini S, Broggini M, Faircloth G, D'Incalci M, Mantovani R. Minuzzo M, et al. Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6780-4. doi: 10.1073/pnas.97.12.6780. Proc Natl Acad Sci U S A. 2000. PMID: 10841573 Free PMC article. - Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation.
Jin S, Gorfajn B, Faircloth G, Scotto KW. Jin S, et al. Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6775-9. doi: 10.1073/pnas.97.12.6775. Proc Natl Acad Sci U S A. 2000. PMID: 10841572 Free PMC article. - Unique features of the mode of action of ET-743.
D'Incalci M, Erba E, Damia G, Galliera E, Carrassa L, Marchini S, Mantovani R, Tognon G, Fruscio R, Jimeno J, Faircloth GT. D'Incalci M, et al. Oncologist. 2002;7(3):210-6. doi: 10.1634/theoncologist.7-3-210. Oncologist. 2002. PMID: 12065793 Review. - ET-743: more than an innovative mechanism of action.
Scotto KW. Scotto KW. Anticancer Drugs. 2002 May;13 Suppl 1:S3-6. Anticancer Drugs. 2002. PMID: 12173491 Review.
Cited by
- Trabectedin and Lurbinectedin Modulate the Interplay between Cells in the Tumour Microenvironment-Progresses in Their Use in Combined Cancer Therapy.
Povo-Retana A, Landauro-Vera R, Alvarez-Lucena C, Cascante M, Boscá L. Povo-Retana A, et al. Molecules. 2024 Jan 9;29(2):331. doi: 10.3390/molecules29020331. Molecules. 2024. PMID: 38257245 Free PMC article. Review. - Recent Advancement in Anticancer Compounds from Marine Organisms: Approval, Use and Bioinformatic Approaches to Predict New Targets.
Santaniello G, Nebbioso A, Altucci L, Conte M. Santaniello G, et al. Mar Drugs. 2022 Dec 28;21(1):24. doi: 10.3390/md21010024. Mar Drugs. 2022. PMID: 36662197 Free PMC article. Review. - Enriching cancer pharmacology with drugs of marine origin.
Jimenez PC, Wilke DV, Branco PC, Bauermeister A, Rezende-Teixeira P, Gaudêncio SP, Costa-Lotufo LV. Jimenez PC, et al. Br J Pharmacol. 2020 Jan;177(1):3-27. doi: 10.1111/bph.14876. Epub 2019 Dec 23. Br J Pharmacol. 2020. PMID: 31621891 Free PMC article. Review. - The FUS-DDIT3 Interactome in Myxoid Liposarcoma.
Yu JSE, Colborne S, Hughes CS, Morin GB, Nielsen TO. Yu JSE, et al. Neoplasia. 2019 Aug;21(8):740-751. doi: 10.1016/j.neo.2019.05.004. Epub 2019 Jun 17. Neoplasia. 2019. PMID: 31220736 Free PMC article. - Marine drugs for cancer: surfacing biotechnological innovations from the oceans.
Jimenez PC, Wilke DV, Costa-Lotufo LV. Jimenez PC, et al. Clinics (Sao Paulo). 2018 Aug 20;73(suppl 1):e482s. doi: 10.6061/clinics/2018/e482s. Clinics (Sao Paulo). 2018. PMID: 30133563 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous